Results 11 to 20 of about 67,974,619 (226)

Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus [PDF]

open access: yesНаучно-практическая ревматология, 2020
Neuropsychiatric disorders in juvenile-onset systemic lupus erythematosus (SLE) stay in the focus of attention in recent decades due to significant influence of CNS lesions on SLE course in general, necessity to optimize therapeutic interventions and ...
M. I. Kaleda, I. P. Nikishina
doaj   +4 more sources

Neuropsychiatric Involvement in Juvenile-Onset Systemic Lupus Erythematosus [PDF]

open access: yesNeurology Research International, 2018
Objective. Systemic lupus erythematosus (SLE) is a complex autoimmune disorder characterized by multisystem involvement, including the nervous system.
Mohammad-Amin Khajezadeh   +5 more
doaj   +3 more sources

Low disease activity state in juvenile-onset systemic lupus erythematosus

open access: yesLupus, 2021
Objectives To determine the rate of achieving The Lupus Low Disease Activity State (LLDAS) in children with systemic lupus erythematosus (SLE) for tracing pertinent treatment modalities.
Ayaz, Nuray Aktay   +26 more
core   +4 more sources

Assessment of hematologic indices for diagnosis in juvenile systemic lupus erythematosus

open access: yesRheumatology
Introduction The aim was to present effective approaches utilizing novel hematological parameters for early diagnosis of juvenile-onset systemic lupus erythematosus (jSLE).
Gülcan Özomay Baykal   +2 more
doaj   +2 more sources

Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus.

open access: yesAnnals of the Rheumatic Diseases, 2009
OBJECTIVE: To investigate differences in clinical signs and symptoms, and in antinuclear antibodies (ANA), between patients with juvenile-onset and adult-onset systemic lupus erythematosus (SLE). METHODS: Clinical and serological data of 56 patients with
Joos, Rik   +19 more
core   +3 more sources

Quality of life in patients with juvenile-onset systemic lupus erythematosus

open access: yesJournal of V. N. Karazin Kharkiv National University: Series Medicine
Background. Childhood-onset systemic lupus erythematosus (cSLE) is a rare, multisystem, and potentially life-threatening autoimmune disease with significant comorbidities and the development of a chronic, debilitating condition for the patient.
L.F. Bohmat   +3 more
doaj   +2 more sources

Juvenile-onset systemic lupus erythematosus

open access: yes, 2013
Paediatric or juvenile-onset systemic lupus erythematosus (JSLE) is a rare autoimmune condition, differing from the adult form in terms of severity, organ manifestations, and a less striking female predominance.
Michael W. Beresford, Louise Watson
core   +2 more sources

The role of hsa_circ_0008945 in juvenile-onset systemic lupus erythematosus

open access: yesBMC Medical Genomics, 2023
Abstract Background circular RNAs (circRNAs) play a crucial role in many physiological and pathological processes including juvenile-onset systemic lupus erythematosus (JSLE). The aim of this study is to investigate the role of circRNA hsa_circ_0008945 in JSLE and evaluate its significance as diagnosing biomarker.
Qifan Wang   +6 more
openaire   +3 more sources

Vasculitis in Juvenile-Onset Systemic Lupus Erythematosus [PDF]

open access: yesFrontiers in Pediatrics, 2019
Juvenile-onset systemic lupus erythematosus (JSLE) is a rare, heterogeneous multisystem autoimmune disease that can affect any organ, and present with diverse clinical and serological manifestations. Vasculitis can be a feature of JSLE. It more commonly presents as cutaneous vasculitis than visceral vasculitis, which can affect the central nervous ...
Eve M. D. Smith   +4 more
openaire   +4 more sources

Rituximab therapy for juvenile-onset systemic lupus erythematosus [PDF]

open access: yesPediatric Nephrology, 2007
Rituximab (RTX), an anti-CD20 monoclonal antibody, has been proposed for use in the therapy of systemic lupus erythematosus (SLE). We present the initial long-term experience of the safety and efficacy of rituximab for treatment of SLE in children.
Nwobi, Obioma   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy